UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Activation of P2X7 promotes cerebral edema and neurological injury after traumatic brain injury in mice

PloS one, 2012-07, Vol.7 (7), p.e41229

2012

Volltextzugriff (PDF)

Quality of Life and Body Region Affected by Psoriasis: A Systematic Review

Actas dermo-sifiliográficas, 2023-01, Vol.114 (1), p.33-38

2023

Volltextzugriff (PDF)

Survival of the fittest

British journal of dermatology (1951), 2018-02, Vol.178 (2), p.328-329

Vender, R.

2018

Volltextzugriff (PDF)

High mobility group box protein-1 promotes cerebral edema after traumatic brain injury via activation of toll-like receptor 4

Glia, 2014-01, Vol.62 (1), p.26-38

2014

Volltextzugriff (PDF)

Revisiting Traumatic Brain Injury: From Molecular Mechanisms to Therapeutic Interventions

Biomedicines, 2020-09, Vol.8 (10), p.389

2020

Volltextzugriff (PDF)

A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 24‐week efficacy and safety results from a randomized, double‐blinded trial

British journal of dermatology (1951), 2021-06, Vol.184 (6), p.1047-1058

2021

Volltextzugriff (PDF)

Neutrophil extracellular traps exacerbate neurological deficits after traumatic brain injury

Science advances, 2020-05, Vol.6 (22), p.eaax8847-eaax8847

2020

Volltextzugriff (PDF)

Incidence and prognosis of COVID‐19 in psoriasis patients on biologic therapy: a multicentre retrospective cohort study

Journal of the European Academy of Dermatology and Venereology, 2021-08, Vol.35 (8), p.e485-e487

2021

Volltextzugriff (PDF)

Granulocyte–macrophage colony‐stimulating factor (GM‐CSF) as a therapeutic target in psoriasis: randomized, controlled investigation using namilumab, a specific human anti‐GM‐CSF monoclonal antibody

British journal of dermatology (1951), 2019-06, Vol.180 (6), p.1352-1360

2019

Volltextzugriff (PDF)

Speed of clinical improvement in the real‐world setting from patient‐reported Psoriasis Symptoms and Signs Diary: Secondary outcomes from the Psoriasis Study of Health Outcomes through 12 weeks

Journal of the European Academy of Dermatology and Venereology, 2023-09, Vol.37 (9), p.1825-1840

2023

Volltextzugriff (PDF)

Effectiveness and safety of risankizumab dose optimization in adult patients with plaque psoriasis: An international multicentre retrospective cohort study

Journal of the European Academy of Dermatology and Venereology, 2024-10

2024

Volltextzugriff (PDF)

Integrated safety analysis of treatment‐emergent eczematous reactions in patients with moderate‐to‐severe psoriasis treated with ixekizumab, etanercept and ustekinumab

British journal of dermatology (1951), 2021-10, Vol.185 (4), p.865-867

2021

Volltextzugriff (PDF)

Opposing Roles for Reactive Astrocytes following Traumatic Brain Injury

Neuro-Signals, 2008-01, Vol.16 (2-3), p.154-164

2008

Volltextzugriff (PDF)

Incidence and prognosis of COVID‐19 in patients with psoriasis on apremilast: a multicentre retrospective cohort study

Journal of the European Academy of Dermatology and Venereology, 2022-02, Vol.36 (2), p.e94-e95

2022

Volltextzugriff (PDF)

Biosimilars for psoriasis: worldwide overview of regulatory guidelines, uptake and implications for dermatology clinical practice

British journal of dermatology (1951), 2017-12, Vol.177 (6), p.1495-1502

2017

Volltextzugriff (PDF)

Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyond

Journal of the European Academy of Dermatology and Venereology, 2021-04, Vol.35 (4), p.797-806

2021

Volltextzugriff (PDF)

Pilot Study of Remote Ischemic Conditioning in Acute Spontaneous Intracerebral Hemorrhage

Frontiers in neuroscience, 2022-05, Vol.16, p.791035-791035

2022

Volltextzugriff (PDF)

Long-term treatment with oral N-acetylcysteine: Affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial

Journal of cystic fibrosis, 2015-03, Vol.14 (2), p.219-227

2015

Volltextzugriff (PDF)

Overexpression of Nrf2 attenuates Carmustine-induced cytotoxicity in U87MG human glioma cells

BMC cancer, 2015-03, Vol.15 (1), p.118-118, Article 118

2015

Volltextzugriff (PDF)

Anti‐GM‐CSF therapy in psoriasis

British journal of dermatology (1951), 2019-06, Vol.180 (6), p.e234-e234

2019

Volltextzugriff (PDF)

银屑病抗‐GM‐CSF 治疗

British journal of dermatology (1951), 2019-06, Vol.180 (6), p.e251-e251

2019

Volltextzugriff (PDF)

Traumatic Cerebrospinal Fluid Leaks

Otolaryngologic clinics of North America, 2011-08, Vol.44 (4), p.857-873

2011

Volltextzugriff (PDF)

A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene/benzoyl peroxide plus doxycycline vs. oral isotretinoin

British journal of dermatology (1951), 2014-12, Vol.171 (6), p.1508-1516

2014

Volltextzugriff (PDF)

Identification and management of intrathecal baclofen pump complications: a comparison of pediatric and adult patients

Journal of neurosurgery, 2006-01, Vol.104 (1 Suppl), p.9-15

2006

Volltextzugriff (PDF)

Biosimilars for psoriasis: preclinical analytical assessment to determine similarity

British journal of dermatology (1951), 2016-02, Vol.174 (2), p.282-286

2016

Volltextzugriff (PDF)

1 – 25 von 287

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(258)
Mit Volltextzugriff
(224)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Activation of P2X7 promotes cerebral edema and neurological injury after traumatic brain injury in mice

Quality of Life and Body Region Affected by Psoriasis: A Systematic Review

Survival of the fittest

High mobility group box protein-1 promotes cerebral edema after traumatic brain injury via activation of toll-like receptor 4

Revisiting Traumatic Brain Injury: From Molecular Mechanisms to Therapeutic Interventions

A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 24‐week efficacy and safety results from a randomized, double‐blinded trial

Neutrophil extracellular traps exacerbate neurological deficits after traumatic brain injury

Incidence and prognosis of COVID‐19 in psoriasis patients on biologic therapy: a multicentre retrospective cohort study

Granulocyte–macrophage colony‐stimulating factor (GM‐CSF) as a therapeutic target in psoriasis: randomized, controlled investigation using namilumab, a specific human anti‐GM‐CSF monoclonal antibody

Speed of clinical improvement in the real‐world setting from patient‐reported Psoriasis Symptoms and Signs Diary: Secondary outcomes from the Psoriasis Study of Health Outcomes through 12 weeks

Effectiveness and safety of risankizumab dose optimization in adult patients with plaque psoriasis: An international multicentre retrospective cohort study

Integrated safety analysis of treatment‐emergent eczematous reactions in patients with moderate‐to‐severe psoriasis treated with ixekizumab, etanercept and ustekinumab

Opposing Roles for Reactive Astrocytes following Traumatic Brain Injury

Incidence and prognosis of COVID‐19 in patients with psoriasis on apremilast: a multicentre retrospective cohort study

Biosimilars for psoriasis: worldwide overview of regulatory guidelines, uptake and implications for dermatology clinical practice

Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyond

Pilot Study of Remote Ischemic Conditioning in Acute Spontaneous Intracerebral Hemorrhage

Long-term treatment with oral N-acetylcysteine: Affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial

Overexpression of Nrf2 attenuates Carmustine-induced cytotoxicity in U87MG human glioma cells

Anti‐GM‐CSF therapy in psoriasis

银屑病抗‐GM‐CSF 治疗

Traumatic Cerebrospinal Fluid Leaks

A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene/benzoyl peroxide plus doxycycline vs. oral isotretinoin

Identification and management of intrathecal baclofen pump complications: a comparison of pediatric and adult patients

Biosimilars for psoriasis: preclinical analytical assessment to determine similarity

Suchergebnisse filtern